STEP UP to Avert Amputation in Diabetes (STEP UP)
Diabetes, Foot Ulcer
About this trial
This is an interventional prevention trial for Diabetes focused on measuring self-care, self-monitoring, secondary prevention, foot ulcer, Diabetic Foot Ulcer
Eligibility Criteria
Inclusion Criteria:
- Adults (21 years) with Type 2 diabetes
- History of healed diabetic foot ulcer (>3 months)
- Diabetes therapy for > 6 months
- An available phone and receiving continuity of care at the VA (at least 2 primary care visits in the previous 1.5 years at the recruitment site)
Exclusion Criteria:
- Patients with an active foot ulcer
- Acute cardiovascular disease (CVD) events < 3 months ago
- Poor estimated short-term survival (< 1 year)
- Recent major surgery (< 3 months)
- Prior foot amputation
- Inability to exercise
- Temporary residence in the area
- Inability to provide consent will be excluded
Sites / Locations
- Manhattan Campus of the VA NY Harbor Healthcare System, New York, NY
Arms of the Study
Arm 1
Arm 2
Experimental
Placebo Comparator
Tailored intervention (TI)
Current Practice (CP)
Participants in this arm will receive a comprehensive intervention based on the Transtheoretical Model and Prospect Theory with the counseling being delivered by health counselors using MI principles. This arm will have biweekly calls for the first two months and then monthly calls for the next four months followed by texts or mailings for months 7-18 with the frequency determine by level of treatment adherence.
This group will receive all the enhancements that the VA has targeted to improve foot risk in diabetes including full EMR functionality, clinical reminders to improve care, and Patient-Centered Medical Home (PCMH) implementation with its benefits for diabetes care. To control for attention and preserve blinding, this group will receive calls and mailings focusing on providing education and prevention strategies for health conditions such as colorectal cancer, influenza, insomnia, vision, dementia, and oral disease. This arm will have biweekly calls for the first two months and then monthly calls for the next four months followed by texts or mailings for months 7-18 with the frequency determine by level of treatment adherence to general health recommendations